HOXA11 and gastric cancer: To determine whether HOXA11 could enhance the peritoneal metastatic ability of gastric cancer cells, we engineered NCI-N87 cell to overexpress HOXA11 (Figure 1E right, F & G), and injected them intraperitoneally into BALB/c mice, along with empty vector controls.